OpenURL Connection Search

Select item for more details and to access through your institution.

Rechallenge chemotherapy as a third line treatment option for metastatic colorectal carcinoma.
Published in:
Ortadogu Medical Journal / Ortadogu Tip Dergisi, 2017, v. 9, n. 4, p. 163, doi. 10.21601/ortadogutipdergisi.296006
By:
- Özaslan, Ersin;
- Bozkurt, Oktay;
- Duran, Ayşe Ocak;
- Uçar, Mahmut;
- İnanç, Mevlude;
- Özkan, Metin
Publication type:
Article
The Retroconversion of Immature Teratoma with Chemotherapy: A Case Report and Review of the Literature.
Published in:
2014
By:
- Bozkurt, Oktay;
- Karaca, Halit;
- Eroğlu, Eray;
- Koyuncu, Sümeyra;
- Berk, Veli;
- Polat, Mevlüde İnanç;
- Duran, Ayşe Ocak;
- Özaslan, Ersin;
- Ordu, Melike;
- Çubukçu, Gülşah;
- Özkan, Metin
Publication type:
Case Study
Factors contributing to survival in hepatic dysfunction due to colorectal cancer.
Published in:
Srpski Arhiv za Celokupno Lekarstvo, 2022, v. 150, n. 11/12, p. 685, doi. 10.2298/SARH220725097T
By:
- Tay, Fatih;
- Büyükkör, Mustafa;
- Duran, Ayşe Ocak
Publication type:
Article
PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma.
Published in:
2021
By:
- Şahinli, Hayriye;
- Akyürek, Nalan;
- Yılmaz, Mukaddes;
- Kandemir, Olcay;
- Duran, Ayşe Ocak;
- Kulaçoğlu, Sezer;
- Uçar, Gökhan;
- Acar, Elif;
- Özet, Ahmet;
- Gümüş, Mahmut;
- Öksüzoğlu, Ö. Berna Ç.;
- Özdemir, Nuriye Y.;
- Sahinli, Hayriye;
- Ç Öksüzoğlu, Ö Berna
Publication type:
journal article
Good prognostic factor in patients with nonmetastatic nasopharyngeal carcinoma: Programmed death ligand‑1 expression in tumor cells.
Published in:
Journal of Cancer Research & Therapeutics, 2020, v. 16, p. S43, doi. 10.4103/jcrt.JCRT_759_19
By:
- Şahinli, Hayriye;
- Akyürek, Nalan;
- Yılmaz, Mukaddes;
- Kandemir, Olcay;
- Duran, Ayşe Ocak;
- Kulaçoğlu, Sezer;
- Uçar, Gökhan;
- Acar, Elif;
- Özet, Ahmet;
- Berna, Ö.;
- Öksüzoğlu, Ç.;
- Özdemir, Nuriye Y.
Publication type:
Article
Good prognostic factor in patients with nonmetastatic nasopharyngeal carcinoma: Programmed death ligand-1 expression in tumor cells.
Published in:
2020
By:
- Sahinli, Hayriye;
- Akyürek, Nalan;
- Yılmaz, Mukaddes;
- Kandemir, Olcay;
- Duran, Ayşe;
- Kulaçoǧlu, Sezer;
- Uçar, Gökhan;
- Acar, Elif;
- Özet, Ahmet;
- Öksüzoǧlu, O;
- Özdemir, Nuriye;
- Duran, Ayşe Ocak;
- Öksüzoǧlu, O Berna Ç;
- Özdemir, Nuriye Y
Publication type:
journal article

Found: 6

Rechallenge chemotherapy as a third line treatment option for metastatic colorectal carcinoma.

The Retroconversion of Immature Teratoma with Chemotherapy: A Case Report and Review of the Literature.

Factors contributing to survival in hepatic dysfunction due to colorectal cancer.

PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma.

Good prognostic factor in patients with nonmetastatic nasopharyngeal carcinoma: Programmed death ligand‑1 expression in tumor cells.

Good prognostic factor in patients with nonmetastatic nasopharyngeal carcinoma: Programmed death ligand-1 expression in tumor cells.